Apex Biotechnology Corp (1733) — Free Cash Flow Generation Index
Apex Biotechnology Corp (1733) has a Free Cash Flow Generation Index of 0.43x as of September 2025. Free cash flow of NT$2.22 Million represents 0% of operating cash flow (NT$5.19 Million). Read Apex Biotechnology Corp (1733) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apex Biotechnology Corp Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for Apex Biotechnology Corp across 23 annual periods. Explore Apex Biotechnology Corp capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Apex Biotechnology Corp (2002–2024)
Year-by-year Free Cash Flow Generation Index for Apex Biotechnology Corp. For the full company profile including market capitalisation, see Apex Biotechnology Corp market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$299.04 Million | NT$328.67 Million | NT$29.63 Million | ▲ +2.0% |
| 2023 | 0.89x | NT$205.41 Million | NT$230.39 Million | NT$24.98 Million | ▲ +274.7% |
| 2022 | -0.51x | NT$-13.58 Million | NT$26.62 Million | NT$40.20 Million | ▼ -159.7% |
| 2021 | 0.85x | NT$153.67 Million | NT$179.87 Million | NT$26.20 Million | ▲ +3.2% |
| 2020 | 0.83x | NT$232.28 Million | NT$280.60 Million | NT$48.32 Million | ▼ -5.7% |
| 2019 | 0.88x | NT$405.94 Million | NT$462.52 Million | NT$56.58 Million | ▲ +867.9% |
| 2018 | -0.11x | NT$-7.72 Million | NT$67.57 Million | NT$75.29 Million | ▼ -118.4% |
| 2017 | 0.62x | NT$44.07 Million | NT$70.83 Million | NT$26.76 Million | ▼ -28.6% |
| 2016 | 0.87x | NT$259.60 Million | NT$298.06 Million | NT$38.45 Million | ▼ -7.7% |
| 2015 | 0.94x | NT$445.49 Million | NT$472.15 Million | NT$26.66 Million | ▲ +24.9% |
| 2014 | 0.76x | NT$202.19 Million | NT$267.60 Million | NT$65.41 Million | ▲ +54.5% |
| 2013 | 0.49x | NT$237.08 Million | NT$484.77 Million | NT$247.69 Million | ▲ +162.5% |
| 2012 | 0.19x | NT$94.96 Million | NT$509.67 Million | NT$414.70 Million | ▼ -74.4% |
| 2011 | 0.73x | NT$198.82 Million | NT$273.45 Million | NT$74.63 Million | ▲ +11.2% |
| 2010 | 0.65x | NT$304.53 Million | NT$465.59 Million | NT$161.05 Million | ▼ -19.5% |
| 2009 | 0.81x | NT$317.95 Million | NT$391.29 Million | NT$73.34 Million | ▼ -43.3% |
| 2008 | 1.43x | NT$429.70 Million | NT$299.96 Million | NT$129.74 Million | ▲ +24.6% |
| 2007 | 1.15x | NT$419.34 Million | NT$364.62 Million | NT$54.71 Million | ▲ +3.1% |
| 2006 | 1.12x | NT$405.70 Million | NT$363.71 Million | NT$41.99 Million | ▼ -19.4% |
| 2005 | 1.38x | NT$293.44 Million | NT$212.14 Million | NT$81.30 Million | ▼ -35.6% |
| 2004 | 2.15x | NT$469.70 Million | NT$218.54 Million | NT$251.16 Million | ▲ +81.2% |
| 2003 | 1.19x | NT$358.46 Million | NT$302.25 Million | NT$56.21 Million | ▼ -33.0% |
| 2002 | 1.77x | NT$140.62 Million | NT$79.49 Million | NT$61.13 Million | — |